BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15851684)

  • 1. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3.
    Hong J; Li N; Zhang X; Zheng B; Zhang JZ
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6449-54. PubMed ID: 15851684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
    Fontenot JD; Gavin MA; Rudensky AY
    Nat Immunol; 2003 Apr; 4(4):330-6. PubMed ID: 12612578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans.
    Morgan ME; van Bilsen JH; Bakker AM; Heemskerk B; Schilham MW; Hartgers FC; Elferink BG; van der Zanden L; de Vries RR; Huizinga TW; Ottenhoff TH; Toes RE
    Hum Immunol; 2005 Jan; 66(1):13-20. PubMed ID: 15620457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
    Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
    Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
    Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
    PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function.
    Godfrey WR; Spoden DJ; Ge YG; Baker SR; Liu B; Levine BL; June CH; Blazar BR; Porter SB
    Blood; 2005 Jan; 105(2):750-8. PubMed ID: 15374887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction.
    Oida T; Weiner HL
    PLoS One; 2010 Nov; 5(11):e15523. PubMed ID: 21124798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.
    Hamza E; Gerber V; Steinbach F; Marti E
    Immunology; 2011 Nov; 134(3):292-304. PubMed ID: 21977999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.
    Fantini MC; Becker C; Monteleone G; Pallone F; Galle PR; Neurath MF
    J Immunol; 2004 May; 172(9):5149-53. PubMed ID: 15100250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes.
    Peng Y; Laouar Y; Li MO; Green EA; Flavell RA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4572-7. PubMed ID: 15070759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors.
    Fu S; Zhang N; Yopp AC; Chen D; Mao M; Chen D; Zhang H; Ding Y; Bromberg JS
    Am J Transplant; 2004 Oct; 4(10):1614-27. PubMed ID: 15367216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.
    Piccirillo CA; Letterio JJ; Thornton AM; McHugh RS; Mamura M; Mizuhara H; Shevach EM
    J Exp Med; 2002 Jul; 196(2):237-46. PubMed ID: 12119348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells.
    Zheng SG; Wang JH; Stohl W; Kim KS; Gray JD; Horwitz DA
    J Immunol; 2006 Mar; 176(6):3321-9. PubMed ID: 16517699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus.
    Liang S; Alard P; Zhao Y; Parnell S; Clark SL; Kosiewicz MM
    J Exp Med; 2005 Jan; 201(1):127-37. PubMed ID: 15630140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
    Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
    J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor early growth response 3 is associated with the TGF-β1 expression and the regulatory activity of CD4-positive T cells in vivo.
    Sumitomo S; Fujio K; Okamura T; Morita K; Ishigaki K; Suzukawa K; Kanaya K; Kondo K; Yamasoba T; Furukawa A; Kitahara N; Shoda H; Shibuya M; Okamoto A; Yamamoto K
    J Immunol; 2013 Sep; 191(5):2351-9. PubMed ID: 23904169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.